|
🐜
|
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis.
17 auth.
R. Furie,
B. Rovin,
F. Houssiau,
A. Malvar,
Y. Teng,
G. Contreras,
Z. Amoura,
Xueqing Yu,
C. Mok,
M. Santiago,
...
A. Saxena,
Y. Green,
B. Ji,
C. Kleoudis,
S. Burriss,
Carly Barnett,
D. Roth
|
9 |
2020 |
9
🐜
|
|
🐜
|
Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty‐Two–Week Randomized, Double‐Blind, Placebo‐Controlled Study
12 auth.
W. Stohl,
A. Schwarting,
M. Okada,
M. Scheinberg,
A. Doria,
A. Hammer,
...
C. Kleoudis,
J. Groark,
D. Bass,
N. Fox,
D. Roth,
D. Gordon
|
8 |
2017 |
8
🐜
|
|
🐜
|
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group.
17 auth.
W. Sandborn,
W. Tremaine,
D. Wolf,
S. Targan,
C. Sninsky,
L. Sutherland,
S. Hanauer,
J. McDonald,
B. Feagan,
R. Fedorak,
...
K. Isaacs,
M. Pike,
D. Mays,
J. Lipsky,
S. Gordon,
C. Kleoudis,
R. Murdock
|
7 |
1999 |
7
🐜
|
|
🐜
|
Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain
11 auth.
L. Webster,
J. Jansen,
J. Peppin,
B. Lasko,
G. Irving,
B. Morlion,
...
J. Snidow,
A. Pierce,
E. Mortensen,
C. Kleoudis,
E. Carter
|
7 |
2008 |
7
🐜
|
|
🐜
|
A dose‐ranging, placebo‐controlled, randomized trial of alosetron in patients with functional dyspepsia
8 auth.
N. Talley,
S. V. Zanten,
L. Sáez,
G. Dukes,
T. B. Perschy,
Mark R. Heath,
...
C. Kleoudis,
A. Mangel
|
6 |
2001 |
6
🐜
|
|
🐜
|
Heartburn requiring frequent antacid use may indicate significant illness.
9 auth.
M. Robinson,
D. Earnest,
S. Rodriguez-Stanley,
B. Meerveld,
P. Jaffe,
Marianne T. Silver,
...
C. Kleoudis,
Lynn E. Wilson,
R. Murdock
|
6 |
1998 |
6
🐜
|
|
🐜
|
A randomized, placebo-controlled phase 3 trial (Study SB-767905/012) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain.
10 auth.
J. Jansen,
D. Lorch,
J. Langan,
B. Lasko,
K. Hermanns,
C. Kleoudis,
...
J. Snidow,
A. Pierce,
J. Wurzelmann,
E. Mortensen
|
6 |
2011 |
6
🐜
|
|
🐜
|
A randomized, placebo-controlled phase 3 trial (Study SB-767905/013) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain.
11 auth.
G. Irving,
J. Pénzes,
B. Ramjattan,
M. Cousins,
R. Rauck,
E. Spierings,
...
C. Kleoudis,
J. Snidow,
A. Pierce,
J. Wurzelmann,
E. Mortensen
|
6 |
2011 |
6
🐜
|
|
🐜
|
A randomized, open-label study to investigate the effect of belimumab on pneumococcal vaccination in patients with active, autoantibody-positive systemic lupus erythematosus
7 auth.
W. W. Chatham,
A. Chadha,
J. Fettiplace,
C. Kleoudis,
D. Bass,
D. Roth,
...
Duncan A. Gordon
|
5 |
2017 |
5
🐜
|
|
🐜
|
Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response
8 auth.
Ronald F van Vollenhoven,
Michelle A. Petri,
Ricard Cervera,
David A Roth,
B. Ji,
C. Kleoudis,
...
Z. Zhong,
W. Freimuth
|
5 |
2012 |
5
🐜
|
